Octahydroaminoacridine succinate
- Generic Name
- Octahydroaminoacridine succinate
Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease
Phase 3
- Conditions
- Alzheimer Disease
- Interventions
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- Shanghai Mental Health Center
- Target Recruit Count
- 600
- Registration Number
- NCT03283059
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath